Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia

Akio Kodama(Asahikawa Medical University), Nobuyoshi Azuma(Asahikawa Medical University), Osamu Iida(Osaka Police Hospital), Daizo Kawasaki, Yoshimitsu Soga(Kokura Memorial Hospital), Mitsuyoshi Takahara(The University of Osaka), Yuichi Izumi, Shinsuke Mii, Kimihiro Komori(Saiseikai Yahata General Hospital), Hiroto Terashi(Asahikawa Medical University)
Journal of Atherosclerosis and Thrombosis
May 26, 2021
10.5551/jat.62892
Cited by 9

Related Papers

Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia
|European Journal of Vascular and Endovascular Surgery|2019|522
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial
|The Lancet|2018|288
Angiogenic Gene Therapy for Experimental Critical Limb Ischemia
|Circulation Research|2002|238